Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
It is classified as a triple receptor agonist for its simultaneous activity at the GIP, GLP-1, and glucagon receptors, and is intended strictly for in vitro laboratory research ONLY
Contraindications Known hypersensitivity to any of the components Not recommended during pregnancy or lactation without medical supervision Warnings & Precautions Keep out of reach of children Use cautiously in patients with renal impairment Not a substitute for a varied diet or treatment of chronic diseases Adverse Effects Generally well tolerated
Provided as a 10mg vial, it is intended for controlled experimental use by qualified professionals
Patients are reporting significant weight loss, sometimes comparable to bariatric surgery, coupled with improved blood sugar control and an overall feeling of well-being
Ah yes, because Covid-19 vaccines were only about reduced risk of death, not losing weight
The degree of receptor activation is typically reported as the peptide concentration required for a response to reach 50% of its maximal value, known as the half-maximal effective concentration (EC 50 )
US$ 21.11
US$ 21.79
US$ 20.68
